Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A 12‑month randomized open‑label dose‑finding study of oral AEB071 versus Neoral in renal transplant recipients
2006-004540-23Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sotrastaurin in kidney transplant (2 arms), sponsored by Novartis. Primary endpoint: Composite efficacy failure at 3 months. Started May 2007; status: completed.
02
Drugs
sotrastaurin
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2006-004540-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004540-23.